Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
US Army
Mallinckrodt
Johnson and Johnson
Cerilliant
McKesson
Federal Trade Commission
Cipla
Queensland Health

Generated: December 15, 2018

DrugPatentWatch Database Preview

Litigation Details for Baker v. MBNA Corp. (D. Del. 2005)

« Back to Dashboard

Baker v. MBNA Corp. (D. Del. 2005)

Docket ➤ Try a Free Trial Date Filed 2005-05-05
Court District Court, D. Delaware Date Terminated 2009-10-06
Cause 15:78m(a) Securities Exchange Act Assigned To Gregory Moneta Sleet
Jury Demand Plaintiff Referred To
Parties ACTIVEST INVESTMENTGESELLSCHAFT MBH; ARCA S G R SPA; BRUCE L. HAMMONDS; CHARLES C. KRULAK; CITY OF DEERFIELD BEACH NON-UNIFORM EMPLOYEES RETIREMENT PLAN; JAMES M. BAKER; JOHN R. COCHRAN, III; JOHN W. SCHEFLEN; KENNETH A. VECCHIONE; LANCE L. WEAVER; MBNA CORP.; MICHAEL G. RHODES; RALPH SIANNI; RICHARD K. STRUTHERS; SOCIETE GENERALE SECURITIES SERVICES KAPITALANLAGEGESELLSCHAFT MBH
Patents 4,721,723
Attorneys Ann Ritter; Brian D. Long; Caroline Bernard; Gregg S. Levin; Jeffrey S. Goddess; John McConnell; Marc H. Snyder; Martha H. Rhodes; Meghan S.B. Oliver; Michele Sherretta Budicak; Ralph Nicholas Sianni; Richard H. Morse; Seth D. Rigrodsky; William E. Applegate , IV; William Narwold
Firms Rigrodsky & Long, P.A.; Rosen Moss Snyder & Bleefeld; Rosenthal, Monhait & Goddess, P.A.; Stewarts Law US LLP, I.M. Pei Building; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Baker v. MBNA Corp.
The small molecule drugs covered by the patent cited in this case are ➤ Try a Free Trial and ➤ Try a Free Trial .

Details for Baker v. MBNA Corp. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2008-08-01 130 Exhibit Tabs 1-3 to Compendium of Unreported Opinions Cited in Plaintiffs' Defendants infringed Patent No. 4,721,723 (“the '723 Patent”), which the United States Patent and Trademark… named inventors in the ‘723 patent, Defendants argue the '723 patent is invalid under 35 U.S.'…validity of the patent Bristol~Myers does not say 'notiication letters to patent*holders must assert…#39;723 patent SmithKline argues topics 15~17 are irrelevant to the interpretation of the patent claim …collecn'vely “SmithKline”) idled a one»count patent infringement complaint against Defendants Apotex External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Julphar
Cerilliant
Chubb
Fuji
QuintilesIMS
Citi
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.